Alembic Pharma converts UAE branch office into wholly owned subsidiary
Written By : Ruchika Sharma
Published On 2025-11-07 06:00 GMT | Update On 2025-11-07 06:00 GMT
Advertisement
Vadodara: Alembic Pharma has announced that the Company's Branch office in the United Arab Emirates has been converted into a Wholly Owned Subsidiary (WOS) of the Company with the name Alembic Pharmaceuticals Scientific Office L.L.C.
The cost of acquisition of the new Wholly Owned Subsidiary is AED 50,000 in cash.
Read also: Alembic Pharma gets USFDA okay for Triamcinolone Acetonide Injectable Suspension
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.